# Vitamin E for NASH Treatment in HIV Infected Individuals

> **NCT03669133** · PHASE2 · TERMINATED · sponsor: **Indiana University** · enrollment: 3 (actual)

## Conditions studied

- NAFLD
- NASH - Nonalcoholic Steatohepatitis
- HIV Infections

## Interventions

- **DRUG:** Vitamin E
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03669133
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-01
- **Primary completion:** 2021-03-08
- **Final completion:** 2021-03-08
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** lack of coordinator resources and lack of access to study resources during and due to the COVID pandemic
- **Last updated:** 2023-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03669133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03669133, "Vitamin E for NASH Treatment in HIV Infected Individuals". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03669133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*